NASH ASH vs. MAFLD: Diagnostic and Treatment Implications

NASH ASH vs. MAFLD: Diagnostic and Treatment Implications

MAFLD is part of a systemic inflammatory process and other diseases (cardiovascular) are associated More prevalent than previously estimated Hispanics and diabetics at particular risk Biopsy is required for research studies not practical in clinical practice, steatosis benign from hepatic point of view, NASH can progress to cirrhosis Smoking and excess alcohol are bad, but coffee, tea and sleep likely good